Merck & Co Inc (NYSE:MRK)

59.58
Data as of Dec 19
 +0.60 / +1.02%
Today’s Change
48.53
Today|||52-Week Range
62.20
+19.04%
Year-to-Date
Merck Up on OncoEthix Acquisition Deal, Oncology in Focus - Analyst Blog
Dec 19 / Zacks.com
Merck Reveals Data from Breast Cancer Study on Keytruda - Analyst Blog
Dec 11 / Zacks.com
Tetraphase Spikes on Encouraging Data on Antibiotic - Analyst Blog
Dec 19 / Zacks.com
Merck suspends trial of Ebola vaccine
Dec 11 / FT.com
Bull of the Day: Seattle Genetics (SGEN) - Bull of the Day
Dec 19 / Zacks.com
Merck-Cubist Deal On Despite Patent Setback, Shares Fall - Analyst Blog
Dec 10 / Zacks.com
NPS Pharmaceuticals and Shire Up on Takeover Rumors - Analyst Blog
Dec 18 / Zacks.com
3 High-Yield Dividend Stocks to Buy in December
Dec 10 / MotleyFool.com
2014 Healthcare Stock Report Card: Sobek Tracks His Hits and Misses
Dec 18 / TheStreet.com
Cubist Shoots Up on $9.5 Billion Buyout Offer from Merck - Analyst Blog
Dec 09 / Zacks.com
Options Traders Buy the Pullback in Pharmaceuticals Giant Merck
Dec 18 / TheStreet.com
Biotech ETFs in Focus on Cubist Takeover Deal - ETF News And Commentary
Dec 09 / Zacks.com
Juno Therapeutics vies for cancer treatment lead
Dec 17 / FT.com
Merck's New Oncology Product Positive in Early Study - Analyst Blog
Dec 08 / Zacks.com
Roche Submitted NDA for Melanoma Combination Drug - Analyst Blog
Dec 16 / Zacks.com
Superbug threat drives $9.5bn Merck deal
Dec 08 / FT.com
The 3 Most Exceptional CEOs of 2014
Dec 16 / MotleyFool.com
Merck/Cubist: pony up
Dec 08 / FT.com
Twitter's Favorite Biotech and Pharma Stocks
Dec 16 / MotleyFool.com
Why Shares of Cubist Pharmaceuticals Inc Skyrocketed
Dec 08 / MotleyFool.com
A Shift From Healthcare To Discretionary
Dec 16 / StockTwits
Time to Buy This Dip in Gilead Sciences, Inc. Stock?
Dec 08 / MotleyFool.com
It's Not the Zombie Apocalypse, but Killer Superbugs Could Be on the Way
Dec 14 / MotleyFool.com
Why Cubist Pharmaceuticals Inc. Shares Soared in After-Hours Trading on Friday
Dec 08 / MotleyFool.com
Dow 30 Stock Roundup: Chevron Acquires New Zealand Exploration Rights, Merck Announce...
Dec 12 / Zacks.com
Cubist move highlights antibiotics appeal
Dec 07 / FT.com
Best Dividend Paying Stocks Analysts Like in the Dow
Dec 12 / DividendChannel.com
Ebola vaccine shows promise in trials
Nov 26 / FT.com

To view my watchlist

Not a member yet?

Sign up now for a free account

Most stock quote data provided by BATS. Market indices are shown in real time, except for the DJIA, which is delayed by two minutes. All times are ET. Disclaimer.

Morningstar: © 2014 Morningstar, Inc. All Rights Reserved.

Factset: FactSet Research Systems Inc. 2014. All rights reserved.

Chicago Mercantile Association: Certain market data is the property of Chicago Mercantile Exchange Inc. and its licensors. All rights reserved.

Dow Jones: The Dow Jones branded indices are proprietary to and are calculated, distributed and marketed by DJI Opco, a subsidiary of S&P Dow Jones Indices LLC and have been licensed for use to S&P Opco, LLC and CNN. Standard & Poor's and S&P are registered trademarks of Standard & Poor’s Financial Services LLC and Dow Jones is a registered trademark of Dow Jones Trademark Holdings LLC. All content of the Dow Jones branded indices © S&P Dow Jones Indices LLC 2014 and/or its affiliates.